Cargando…

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study

BACKGROUND: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Otabil, Kenneth Bentum, Basáñez, María-Gloria, Ankrah, Blessing, Bart-Plange, Emmanuel John, Babae, Theophilus Nti, Kudzordzi, Prince-Charles, Darko, Vera Achiaa, Raji, Abdul Sakibu, Datsa, Lydia, Boakye, Andrews Agyapong, Yeboah, Michael Tawiah, Fodjo, Joseph Nelson Siewe, Schallig, Henk D. F. H., Colebunders, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655298/
https://www.ncbi.nlm.nih.gov/pubmed/37974087
http://dx.doi.org/10.1186/s12879-023-08806-8
_version_ 1785147915561336832
author Otabil, Kenneth Bentum
Basáñez, María-Gloria
Ankrah, Blessing
Bart-Plange, Emmanuel John
Babae, Theophilus Nti
Kudzordzi, Prince-Charles
Darko, Vera Achiaa
Raji, Abdul Sakibu
Datsa, Lydia
Boakye, Andrews Agyapong
Yeboah, Michael Tawiah
Fodjo, Joseph Nelson Siewe
Schallig, Henk D. F. H.
Colebunders, Robert
author_facet Otabil, Kenneth Bentum
Basáñez, María-Gloria
Ankrah, Blessing
Bart-Plange, Emmanuel John
Babae, Theophilus Nti
Kudzordzi, Prince-Charles
Darko, Vera Achiaa
Raji, Abdul Sakibu
Datsa, Lydia
Boakye, Andrews Agyapong
Yeboah, Michael Tawiah
Fodjo, Joseph Nelson Siewe
Schallig, Henk D. F. H.
Colebunders, Robert
author_sort Otabil, Kenneth Bentum
collection PubMed
description BACKGROUND: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persistent Onchocerca volvulus infection. METHODS: In August 2021, a cross-sectional mixed-methods study was conducted in 13 onchocerciasis-endemic communities in the Bono Region of Ghana. Individuals aged ≥ 10 years were invited to participate in a questionnaire survey. A total of 48 focus group discussions and in-depth interviews with 10 community drug distributors and 13 community leaders were conducted. RESULTS: A total of 510 people participated in the study [median age: 32, interquartile range 30 (20‒50) years]; 274 (53.7%) were females. Of the total, 320 (62.7%) declared that they adhered to each treatment round and 190 (37.3%) admitted they had not taken ivermectin during at least one MDA round, since becoming eligible for treatment. Of 483 participants with complete information, 139 (28.8%) did not take ivermectin during the last round (March 2021), and 24 (5.0%) had never taken ivermectin (systematic non-adherers). Reasons for not taking ivermectin included previous experience/fear of side-effects, being absent during MDA, pregnancy, the desire to drink alcohol, and drug distribution challenges. Being male, having good knowledge and perception of the disease, and not having secondary or higher level of formal education were significantly associated with higher odds of ivermectin intake. CONCLUSIONS: A relatively high level of non-adherence to ivermectin treatment was documented. There is a need for targeted educational and behavioural change campaigns to reverse these trends and ensure a steady course toward meeting onchocerciasis elimination targets in Ghana. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08806-8.
format Online
Article
Text
id pubmed-10655298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106552982023-11-16 Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study Otabil, Kenneth Bentum Basáñez, María-Gloria Ankrah, Blessing Bart-Plange, Emmanuel John Babae, Theophilus Nti Kudzordzi, Prince-Charles Darko, Vera Achiaa Raji, Abdul Sakibu Datsa, Lydia Boakye, Andrews Agyapong Yeboah, Michael Tawiah Fodjo, Joseph Nelson Siewe Schallig, Henk D. F. H. Colebunders, Robert BMC Infect Dis Research BACKGROUND: The World Health Organization has proposed that onchocerciasis elimination (interruption) of transmission be verified in 12 (approximately a third) endemic countries by 2030. The strategy to reach this goal is based on ivermectin Mass Drug Administration (MDA) with high geographical and therapeutic coverage. In addition to coverage, high levels of treatment adherence are paramount. We investigated factors associated with ivermectin intake in an area of Ghana with persistent Onchocerca volvulus infection. METHODS: In August 2021, a cross-sectional mixed-methods study was conducted in 13 onchocerciasis-endemic communities in the Bono Region of Ghana. Individuals aged ≥ 10 years were invited to participate in a questionnaire survey. A total of 48 focus group discussions and in-depth interviews with 10 community drug distributors and 13 community leaders were conducted. RESULTS: A total of 510 people participated in the study [median age: 32, interquartile range 30 (20‒50) years]; 274 (53.7%) were females. Of the total, 320 (62.7%) declared that they adhered to each treatment round and 190 (37.3%) admitted they had not taken ivermectin during at least one MDA round, since becoming eligible for treatment. Of 483 participants with complete information, 139 (28.8%) did not take ivermectin during the last round (March 2021), and 24 (5.0%) had never taken ivermectin (systematic non-adherers). Reasons for not taking ivermectin included previous experience/fear of side-effects, being absent during MDA, pregnancy, the desire to drink alcohol, and drug distribution challenges. Being male, having good knowledge and perception of the disease, and not having secondary or higher level of formal education were significantly associated with higher odds of ivermectin intake. CONCLUSIONS: A relatively high level of non-adherence to ivermectin treatment was documented. There is a need for targeted educational and behavioural change campaigns to reverse these trends and ensure a steady course toward meeting onchocerciasis elimination targets in Ghana. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08806-8. BioMed Central 2023-11-16 /pmc/articles/PMC10655298/ /pubmed/37974087 http://dx.doi.org/10.1186/s12879-023-08806-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Otabil, Kenneth Bentum
Basáñez, María-Gloria
Ankrah, Blessing
Bart-Plange, Emmanuel John
Babae, Theophilus Nti
Kudzordzi, Prince-Charles
Darko, Vera Achiaa
Raji, Abdul Sakibu
Datsa, Lydia
Boakye, Andrews Agyapong
Yeboah, Michael Tawiah
Fodjo, Joseph Nelson Siewe
Schallig, Henk D. F. H.
Colebunders, Robert
Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
title Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
title_full Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
title_fullStr Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
title_full_unstemmed Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
title_short Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
title_sort non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the bono region of ghana: a mixed-methods study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655298/
https://www.ncbi.nlm.nih.gov/pubmed/37974087
http://dx.doi.org/10.1186/s12879-023-08806-8
work_keys_str_mv AT otabilkennethbentum nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT basanezmariagloria nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT ankrahblessing nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT bartplangeemmanueljohn nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT babaetheophilusnti nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT kudzordziprincecharles nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT darkoveraachiaa nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT rajiabdulsakibu nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT datsalydia nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT boakyeandrewsagyapong nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT yeboahmichaeltawiah nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT fodjojosephnelsonsiewe nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT schallighenkdfh nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy
AT colebundersrobert nonadherencetoivermectininonchocerciasisendemiccommunitieswithpersistentinfectioninthebonoregionofghanaamixedmethodsstudy